Does TAPENTADOL Cause Mobility decreased? 17 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Mobility decreased have been filed in association with TAPENTADOL (Nucynta). This represents 0.1% of all adverse event reports for TAPENTADOL.
17
Reports of Mobility decreased with TAPENTADOL
0.1%
of all TAPENTADOL reports
1
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From TAPENTADOL?
Of the 17 reports, 1 (5.9%) resulted in death, 2 (11.8%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAPENTADOL. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does TAPENTADOL Cause?
Death (11,560)
Toxicity to various agents (9,617)
Overdose (5,843)
Drug abuse (1,566)
Drug dependence (1,019)
Drug withdrawal syndrome neonatal (945)
Accidental overdose (693)
Drug ineffective (633)
Pain (436)
Nausea (434)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which TAPENTADOL Alternatives Have Lower Mobility decreased Risk?
TAPENTADOL vs TAPINAROF
TAPENTADOL vs TARCEVA
TAPENTADOL vs TARLATAMAB
TAPENTADOL vs TARLATAMAB-DLLE
TAPENTADOL vs TASIGNA